Results of pairwise and network meta-analyses of repairing rate of metaphyseal lesions on X-ray films
| OR (95% CI) * | Placebo | Se | Se salt | Se+VC | Se+VE | Se yeast |
| Se | 4.68 (2.99 to 7.34)* 5.00 (3.21 to 7.78) | – – | – | – | – | – |
| Se salt | 12.37 (2.81 to 54.41)* 7.60 (2.34 to 24.67) | 2.64 (0.59 to 11.84) – | – | – | – | – |
| Se+VC | 3.26 (1.14 to 9.28)* 1.27 (0.42 to 3.83) | 0.70 (0.25 to 1.97) 1.30 (0.57 to 2.94) | 0.26 (0.06 to 1.20) 0.17 (0.05 to 0.55) | – | – | – |
| Se+VE | 10.72 (3.14 to 36.57)* 11.05 (2.61 to 46.80) | 2.29 (0.62 to 8.43) – | 0.87 (0.13 to 5.93) – | 3.29 (0.65 to 16.53) – | – | – |
| Se yeast | 5.81 (1.70 to 19.89)* 3.75 (1.76 to 8.02) | 1.24 (0.36 to 4.25) 1.92 (0.90 to 4.00) | 0.47 (0.07 to 3.16) – | 1.78 (0.37 to 8.66) – | 0.54 (0.10 to 3.08) – | – |
| VC | 3.05 (1.29 to 7.20)* 2.02 (0.98 to 4.17) | 0.65 (0.28 to 1.53) 0.95 (0.51 to 1.79) | 0.25 (0.06 to 1.06) 0.24 (0.08 to 0.72) | 0.94 (0.34 to 2.56) 0.87 (0.38 to 1.96) | 0.28 (0.06 to 1.27) – | 0.52 (0.12 to 2.27) – |
In each cell, the first line represents the result of network meta-analyses, and the second row represents the result of pairwise meta-analyses.
*ORs represent odds of repair in row treatment versus column treatment. ORs larger than 1 denote higher repair rate in row treatment than column treatment.
Se, sodium selenite; Se salt, selenium salt; Se+VC, the combination of sodium selenite with vitamin C; Se+VE, the combination of sodium selenite with vitamin E; Se yeast, selenium enriched yeast; VC, vitamin C.